Left Appendage Occlusion Device Market Size is valued at 1358.98 Million in 2024 and is predicted to reach 8879.24 Million by the year 2034 at a 20.8% CAGR during the forecast period for 2025-2034.
The left appendage occlusion device is used in procedures such as percutaneous transluminal left atrial appendage occlusion and thoracoscopic left atrial appendage closure. Left appendage occlusion device controls the electrical impulses during atrial fibrillation. During atrial fibrillation, blood clots are pumped out of the heart. This blood can form clots in the atria and LAA. This medical condition can cause a stroke. Left appendage occlusion device is an interventional device used to prevent stroke in atrial fibrillation. Left appendage occlusion device helps in reducing the risk of secondary stroke and emboli because of atrial fibrillation.
The global left appendage occlusion device market is expected to grow rapidly during the forecast period. Clinical evidence of the efficiency of left appendage occlusion devices compared to the standard therapeutic treatment such as warfarin and dabigatran increased awareness levels, and new product launches in new countries are key factors boosting the market growth. However, the complicated implantation procedures and need of experienced surgeons are restraining factors for the market. The stringent regulation procedures for the approval of devices are hindering the new product launches. The vendors focus on clinical trials for new product launches in the high potential market such as the US and the Asia Pacific.
The global left appendage occlusion device market is segmented on the basis of Types, Procedures, End-Users and region. Based on the Type, maket is devided into Endocardial LAA Devices and Epicardial LAA Devices. Secondly, as per produres, the market is segmented into Percutaneous, and Surgical. On the basis of End-User, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Heart Clinics. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that, North America held the largest share of the market, followed by Europe. On the other hand, Asia-Pacific is expected to dominate the market during the analysis of the forecast period.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 1358.98 Million |
|
Revenue Forecast In 2034 |
USD 8879.24 Million |
|
Growth Rate CAGR |
CAGR of 20.8% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Types, By Procedure, By End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
Atricure, Biosense Webster, Boston Scientific, Abbott Laboratories, Aegis Medical, Cardia, Lifetech Scientific, and Sentreheart, and Others |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Left Atrial Appendage Closure Devices Market Snapshot
Chapter 4. Global Left Atrial Appendage Closure Devices Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter’s Five Forces Analysis
4.6. Competitive Landscape & Market Share Analysis
4.7. Clinical Trial/Pipeline Analysis
4.8. COVID 19 Impact Analysis
Chapter 5. Left Atrial Appendage Closure Devices Market Segmentation 1: By Types Estimates & Trend Analysis
5.1. By Products & Market Share, 2024 & 2034
5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Products:
5.2.1. Endocardial LAA Devices
5.2.2. Epicardial LAA Devices
Chapter 6. Left Atrial Appendage Closure Devices Market Segmentation 2: By Procedures Estimates & Trend Analysis
6.1. By Procedures & Market Share, 2024 & 2034
6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Procedures:
6.2.1. Percutaneous
6.2.2. Surgical
Chapter 7. Left Atrial Appendage Closure Devices Market Segmentation 4: By End-Users Estimates & Trend Analysis
7.1. By End-Users Analysis & Market Share, 2024 & 2034
7.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-Users:
7.2.1. Hospital
7.2.2. Ambulatory Surgical Centers
7.2.3. Other End-Users
Chapter 8. Left Atrial Appendage Closure Devices Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Left Atrial Appendage Closure Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Products, 2021-2034
8.1.2. North America Left Atrial Appendage Closure Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Procedures, 2021-2034
8.1.3. North America Left Atrial Appendage Closure Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By End-Users, 2021-2034
8.1.4. North America Left Atrial Appendage Closure Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2021-2034
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe Left Atrial Appendage Closure Devices Market revenue (US$ Million) and volume (No. of Units) By Products, 2021-2034
8.2.2. Europe Left Atrial Appendage Closure Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Procedures, 2021-2034
8.2.3. Europe Left Atrial Appendage Closure Devices Market revenue (US$ Million) and volume (No. of Units) By End-Users, 2021-2034
8.2.4. Europe Left Atrial Appendage Closure Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2021-2034
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific Left Atrial Appendage Closure Devices Market revenue (US$ Million) and volume (No. of Units) By Products, 2021-2034
8.3.2. Asia Pacific Left Atrial Appendage Closure Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Procedures, 2021-2034
8.3.3. Asia Pacific Left Atrial Appendage Closure Devices Market revenue (US$ Million) and volume (No. of Units) By End-Users, 2021-2034
8.3.4. Asia Pacific Left Atrial Appendage Closure Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2021-2034
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America Left Atrial Appendage Closure Devices Market revenue (US$ Million) and volume (No. of Units) By Products, (US$ Million) 2021-2034
8.4.2. Latin America Left Atrial Appendage Closure Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Procedures, 2021-2034
8.4.3. Latin America Left Atrial Appendage Closure Devices Market revenue (US$ Million) and volume (No. of Units) By End-Users, (US$ Million) 2021-2034
8.4.4. Latin America Left Atrial Appendage Closure Devices Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2021-2034
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. MEA
8.5.1. MEA revenue Left Atrial Appendage Closure Devices Market revenue (US$ Million) and volume (No. of Units) By Products, (US$ Million) 2021-2034
8.5.2. MEA Left Atrial Appendage Closure Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Procedures, 2021-2034
8.5.3. MEA revenue Left Atrial Appendage Closure Devices Market revenue (US$ Million) and volume (No. of Units) By End-Users, (US$ Million) 2021-2034
8.5.4. MEA revenue Left Atrial Appendage Closure Devices Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2021-2034
8.5.4.1. South Africa
8.5.4.2. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Abbott Laboratories
9.2.2. ArtiCure, Inc.
9.2.3. Boston Scientific Corporation
9.2.4. Cardia, Inc.
9.2.5. Johnson & Johnson
9.2.6. Lifetech Scientific
9.2.7. Occlutech
9.2.8. SentriHEART, Inc.
9.2.9. Schnell Medical Corp.
9.2.10. Conformal Medical, Inc
9.2.11. Laminar, Inc. (laminarlaa.com)
9.2.12. Eclipse Medical (eclipse-med.com)
9.2.13. Vascular Innovations Co. Ltd.
9.2.14. Append Medical
9.2.15. List of Other Prominent Players
Global Left Appendage Occlusion Device Market by Type
Global Left Appendage Occlusion Device Market Based on Procedures
Global Left Appendage Occlusion Device Market Based on End-User
Global Left Appendage Occlusion Device Market Based on Region
Europe
North America
Asia Pacific
Latin America
Middle East & Africa
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
